Marking the conference and exhibit’s 71st year, Pittcon 2020, organized by the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy was held in Chicago, Illinois from March 1 to March 5 (short courses began February 29). The conference is one of the largest conferences and exhibition for analytical chemists and other scientists. As usual, several […]

Rigaku and Metal Analysis Group will provide advanced analytical solutions for metal analysis throughout North America Wilmington, MA – September 3, 2019.  Rigaku Analytical Devices, Inc. a leader in handheld and portable spectroscopic analyzers, is pleased to announce a new partnership with Metal Analysis Group.  Metal Analysis Group is a premier analytical consulting firm with expertise in elemental […]

Rigaku and Metal Analysis Group will provide advanced analytical solutions for metal analysis throughout North America Rigaku Analytical Devices, Inc. a leader in handheld and portable spectroscopic analyzers, is pleased to announce a new partnership with Metal Analysis Group.  Metal Analysis Group is a premier analytical consulting firm with expertise in elemental analysis for metal production, fabrication, […]

Last month, the specific funding amounts for the Congressionally Directed Medical Research Programs (CDMRP) were released, which are not part of the President’s budget request for Research, Development, Test and Evaluation (RDT&E). CDMRP funding is usually inserted as “Undistributed Medical Research” in the Department of Defense’s (DoD) RDT&E account in budget proposals. The CDMRP provides […]

Over the past few weeks, the US Senate Appropriations Committee has released FY2019 appropriation packages for various departments, including the Department of Energy (DoE) and the National Institutes of Health (NIH). The information below illustrates funding for selected institutes and programs that affect life sciences R&D, and has been extracted from various federal documents, including […]

In May, the NIH released data regarding the annual funding levels classified by disease and condition research based on funding mechanisms, such as grants and contracts. The information came as part of the NIH’s efforts to provide more transparency and improved consistency when reporting its funded research. The new transparency process was implemented in 2008 […]